STA
XRAY icon

Summit Trail Advisors’s Dentsply Sirona XRAY Stock Holding History

Summit Trail Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
97,498
+33,240
+52% +$363K 0.01% 980
2026
Q1 		$745K Buy
64,258
+11,298
+21% +$141K 0.01% 1034
2025
Q4 		$611K Buy
52,960
+3,579
+7% +$42K 0.01% 1018
2025
Q3 		$632K Buy
+49,381
New +$717K 0.01% 1009
2024
Q4 		– Sell
-9,922
Closed -$270K – 794
2024
Q3 		$270K Sell
9,922
-333
-3% -$8.5K 0.01% 581
2024
Q2 		$256K Buy
+10,255
New +$294K 0.01% 526
2018
Q3 		– Sell
-190
Closed -$8K – 458
2018
Q2 		$8K Buy
+190
New +$8.92K ﹤0.01% 444
2018
Q1 		– Sell
-3,544
Closed -$226K – 1691
2017
Q4 		$226K Buy
+3,544
New +$225K 0.03% 387

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Summit Trail Advisors's XRAY Position: Q2 2026 in Review

Summit Trail Advisors increased its Dentsply Sirona (XRAY) stake by 52% in Q2 2026, buying an estimated $363K and bringing the position to 97,498 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #980.

Summit Trail Advisors first reported a position in XRAY in Q4 2017 and has held it in 8 quarters since. 374 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Summit Trail Advisors held 97,498 shares of Dentsply Sirona worth $1.03M as of Q2 2026.
  • Summit Trail Advisors bought 33,240 Dentsply Sirona shares in Q2 2026, an estimated $363K.
  • Dentsply Sirona made up 0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #980 holding.
  • Summit Trail Advisors first reported a position in Dentsply Sirona in Q4 2017 and has held it in 8 quarters since.
  • 374 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.